Browse the evidence

Chronic elevation of glucocorticoids (cortisol) in the elderly impairs the ability to recover from stressful stimuli and contributes to structural brain changes, including hippocampal atrophy and amygdala dysfunction.

Chronic stress leads to persistently high cortisol levels, which can shrink the hippocampus (memory) and overactivate the amygdala (fear/anxiety). This impairs your ability to bounce back from stressful events. Prioritizing stress management techniques is essential for preserving cognitive function and mental health as you age.

The age-related decline in DHEA and DHEAS, combined with stable or elevated cortisol, creates a high cortisol-to-DHEA ratio that contributes to immunosenescence, frailty, and increased mortality risk.

Your body's production of DHEA (an anti-aging hormone) drops significantly with age, while cortisol (stress hormone) often stays high. This imbalance weakens your immune system and contributes to frailty. Managing stress and maintaining physical activity are key to keeping this ratio in check.

Higher baseline plasma concentrations of perfluoroalkyl substances (PFASs), specifically PFOS and PFNA, are associated with greater weight regain during the 6-24 month period following a diet-induced weight loss, primarily in women.

If you are struggling to maintain weight loss, especially as a woman, be aware that environmental chemicals like PFAS (found in non-stick cookware, food packaging, and some water supplies) may blunt your metabolic recovery. This doesn't mean you should stop trying, but it highlights why standard diets might feel harder to maintain for some. Focus on building lean muscle mass to boost RMR, as this study suggests PFAS specifically blunts the natural increase in RMR that usually helps prevent weight regain.

Pregnancy complications such as gestational hypertension, preeclampsia, and intrauterine growth restriction (IUGR) increase the offspring's risk of adult hypertension, cardiovascular disease, and metabolic syndrome through epigenetic modifications and endothelial dysfunction.

If you were born prematurely or with low birth weight due to pregnancy complications, you may have a higher baseline risk for heart disease and diabetes. Regular monitoring of blood pressure and metabolic markers is advisable, even if you maintain a healthy lifestyle.

In men aged 45-55, higher intake of total fat and monounsaturated fatty acids is significantly associated with increased 16-year incidence of coronary heart disease, independent of traditional risk factors.

For men in their 40s and 50s, reducing total fat and monounsaturated fat intake, particularly from animal sources, is associated with a lower risk of heart disease over 16 years. This benefit appears independent of cholesterol levels. Aim to align with National Cholesterol Education Project guidelines, which suggest lower total fat (around 30% of energy) and saturated fat (around 10% of energy), as these levels were linked to significantly reduced CHD risk in this demographic.

In men aged 56-65, dietary lipid intake (total fat, saturated, monounsaturated, polyunsaturated, cholesterol) is not significantly associated with the 16-year incidence of coronary heart disease.

For men in their late 50s and 60s, this study did not find a significant link between dietary fat intake and heart disease risk over 16 years. This does not mean diet is unimportant, but the direct link observed in younger men was not detected here. Factors like competing mortality and other age-related health issues may obscure dietary effects. Focus on overall health rather than just lipid intake.

Low endogenous melatonin production (defined as urinary 6-SMT ≤8 μg/night) is NOT a useful predictor of response to melatonin therapy in insomnia patients.

You do not need to get your melatonin levels tested to decide if melatonin might help your sleep. The study shows that low melatonin levels do not predict whether you will respond to melatonin therapy. Instead, being over 65 is a better indicator of potential benefit.

SIRT1 regulates lipolysis in adipocytes by deacetylating and activating the transcription factor FoxO1, which directly stimulates the expression of the rate-limiting lipolytic enzyme ATGL.

This research explains the biological mechanism behind how caloric restriction and fasting might promote fat loss: by activating SIRT1, which then turns on the genes responsible for breaking down fat (ATGL). It suggests that lifestyle factors activating SIRT1 (like fasting) work by enhancing this specific genetic pathway rather than just through simple calorie counting.

HIV infection causes a state of malnutrition characterized by weight loss, micronutrient deficiencies, and altered metabolism, which accelerates disease progression and increases mortality risk independently of CD4 count.

For individuals with HIV, maintaining adequate nutrition is not just supportive care but a critical component of disease management. Weight loss and micronutrient deficiencies are common and directly linked to faster disease progression and higher mortality, independent of standard immune markers like CD4 counts. Addressing food insecurity, managing side effects that reduce appetite, and ensuring a balanced diet are essential steps to mitigate these risks.

A single administration of senolytic CAR T cells targeting uPAR eliminates senescent cells in aged mice, resulting in improved glucose tolerance, reduced fasting glucose, and enhanced exercise capacity.

This research suggests that targeting senescent cells via a single cellular therapy can reverse age-related metabolic decline and improve physical fitness in mice. While not yet available for human use, it highlights senolytics as a potential future intervention for longevity.

uPAR-targeting CAR T cells effectively treat metabolic syndrome induced by a high-fat diet in young mice, improving body weight, glucose tolerance, and insulin sensitivity.

In a mouse model of obesity, clearing senescent cells via CAR T therapy improved metabolic health and reduced body weight, even when the mice continued to eat a high-fat diet.

The scaffold protein βKlotho (KLB) is an absolute requirement for Fibroblast Growth Factor 21 (FGF21) to exert metabolic effects in vivo; without KLB, FGF21 cannot trigger signaling, alter gene expression, or improve metabolic health.

FGF21 is not a standalone fat-loss drug; it requires the presence of the protein Klotho Beta (KLB) to function. If KLB is absent or defective, FGF21 therapy will be ineffective. This highlights that metabolic treatments must target the entire receptor complex, not just the hormone itself.

Magnesium supplementation above the Tolerable Upper Intake Level (UL) of 250 mg/day from supplements can cause mild diarrhea.

Do not exceed 250 mg/day from magnesium supplements, as this can cause diarrhea. This limit applies to supplements and fortified foods, not naturally occurring magnesium in whole foods.

Saturated fatty acids (SFAs) activate Toll-like receptor 4 (TLR4) in skeletal muscle and adipose tissue, triggering IKK and JNK kinases that phosphorylate IRS proteins on serine residues, thereby blocking insulin signaling and causing insulin resistance.

If you have insulin resistance or obesity, the type of fat you eat matters significantly. High intake of saturated fats (found in fatty meats, butter, cheese) can directly activate immune receptors in your muscle and fat cells, triggering inflammation that blocks insulin from working. Reducing saturated fat intake may help restore insulin sensitivity by lowering this specific inflammatory signaling.

GH improves exercise capacity in GHD through increased oxygen delivery (cardiac output, blood volume) and substrate availability (fat oxidation), not primarily through increased muscle strength.

GH replacement works by improving how your heart pumps blood and how your body burns fat during exercise, rather than just building bigger muscles.

Adiponectin (APN) exerts cardiovascular protective effects by activating AMPK and eNOS pathways, promoting endothelial cell survival, reducing inflammation, and inhibiting atherosclerosis progression.

Maintaining healthy adiponectin levels is crucial for heart health. Since adiponectin levels drop in obesity and diabetes, focusing on reducing visceral fat and improving insulin sensitivity through diet and exercise can help restore these protective hormonal signals. While direct supplementation is not currently standard clinical practice due to production complexities, lifestyle interventions that mimic APN's effects (like exercise-induced AMPK activation) are beneficial.

Obesity and high glucose/high lipid environments induce 'APN resistance' by disrupting the AdipoR1/caveolin signalosome, thereby diminishing the cardioprotective effects of adiponectin.

If you have diabetes or obesity, your body may become resistant to the protective effects of adiponectin. This 'APN resistance' means that simply having the hormone isn't enough; the signaling pathway is broken. Addressing the underlying metabolic stress (glucose/lipid control) is necessary to restore this protective signaling.

High prevalence of overweight (49.3%), hypertension (30.9%), and dyslipidaemia (44.1%) exists in French adults, with men showing higher rates of hypertension and dyslipidaemia while women show higher rates of central obesity and low vitamin D.

Nearly half of adults are overweight, and a third have high blood pressure. Men should prioritize blood pressure and lipid management, while women should focus on central obesity (waist circumference) and vitamin D status, as these are the gender-specific high-risk areas identified.

Cellular senescence drives inflammaging through the secretion of the Senescence-Associated Secretory Phenotype (SASP), which promotes chronic sterile inflammation and age-related pathologies.

Aging is associated with the accumulation of 'zombie' cells (senescent cells) that secrete inflammatory signals (SASP). This chronic inflammation contributes to many age-related diseases. While senolytics (drugs that kill these cells) are being developed, current evidence supports lifestyle factors like physical activity, which improves mitochondrial function and may help manage inflammation.

Mitochondrial dysfunction, specifically the release of mitochondrial DAMPs (mtDAMPs) like oxidized mtDNA and cardiolipin, activates innate immune pathways (NLRP3, cGAS/STING, NF-κB) to drive inflammaging.

Mitochondrial health is crucial for managing inflammation. Impaired mitochondria release signals that trigger chronic inflammation. Physical activity improves mitochondrial function and may help reduce this inflammatory burden.

Sarcolemmal localization of C18:0 ceramide and specific sphingomyelin species is inversely related to insulin sensitivity in human skeletal muscle, whereas sarcolemmal 1,2-DAGs are not significantly related.

Focus on improving insulin sensitivity through exercise and metabolic health rather than just obsessing over total body fat or muscle fat content. The location and type of lipids matter more than the total amount. Endurance training appears to alter lipid localization in a way that preserves insulin sensitivity despite higher total lipid levels.

Chronic glucocorticoid exposure simultaneously activates triglyceride synthesis and lipolysis in inguinal adipose tissue, maintaining neutral fat storage levels while increasing metabolic turnover.

Chronic stress or elevated cortisol levels trigger a complex response in belly fat (inguinal fat) where the body simultaneously builds up and breaks down triglycerides. This high turnover can contribute to metabolic issues like insulin resistance without necessarily causing immediate, visible weight gain. Managing stress is crucial not just for weight, but for the metabolic health of fat tissue.

Chronic administration of the GLP-1 receptor agonist liraglutide leads to desensitization of its gastric emptying (GE) inhibitory effects, whereas its body weight-lowering effects persist without desensitization.

Long-acting GLP-1 medications like liraglutide work by changing how your brain regulates appetite, not by keeping food in your stomach. While you might feel nausea or slowed digestion initially, your body adapts to this GI effect, but the weight loss continues because the brain's hunger signals remain suppressed. This suggests the medication is effective for sustained weight management even after side effects subside.

Higher Neighborhood Socioeconomic Status (NSES) is associated with lower BMI, lower obesity rates, and lower Systolic and Diastolic Blood Pressure in postmenopausal women.

Living in a more affluent neighborhood is linked to significantly lower BMI and blood pressure. This is likely due to better access to healthy food, safer environments for walking, and lower stress levels, highlighting the importance of neighborhood quality for health.